Large-scale sequencing projects have revealed several potential AML driver genes, including NPM1, CEBPA, DNMT3A, TET2, RUNX1, ASXL1, IDH2, and MLL, and have identified critical mutations in FLT3, IDH1, KIT, and RAS. The gene discussed is TET2; the disease is acute myeloid leukemia.